Journal
JOURNAL OF CLINICAL NEUROLOGY
Volume 5, Issue 3, Pages 120-125Publisher
KOREAN NEUROLOGICAL ASSOC
DOI: 10.3988/jcn.2009.5.3.120
Keywords
sirtuins; therapeutic target; longevity; neurodegenerative diseases
Categories
Funding
- Second-Phase of BK (Brain Korea) 21
- National Research Foundation of Korea [전06A1102] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
The sirtuins (SIRTs) are protein-modifying enzymes that are distributed ubiquitously in all organisms. SIRT1 is a mammalian homologue of yeast nicotinamide-adenine-dinucleotide-dependent deacetylase silent informnation regulator 2 (known as Sir2), which is the best-characterized SIRT family member. It regulates longevity in several model organisms and is involved in several processes in mammalian cells including cell survival, differentiation, and metabolism. SIRT1 induction, either by SIRT-activating compounds such as resveratrol, or metabolic conditioning associated with caloric restriction, could have neuroprotective qualities and thus delay the neurodegenerative process, thereby promoting longevity. However, the precise mechanistic liaison between the activation of SIRT and extended healthy aging or delaying age-related diseases in humans has yet to be established. J Clin Neurol 2009;5:120-125
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available